MPC-004 for the Treatment of an Acute Gout Flare
NCT00506883
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
185
Enrollment
INDUSTRY
Sponsor class
Conditions
Gout
Interventions
DRUG:
High Dose Colchicine (4.8 mg total dose)
DRUG:
Low Dose Colchicine (1.8mg total dose)
OTHER:
Placebo Control
Sponsor
Takeda